Atlas Trials

Epidemic Meningitis

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Epidemic Meningitis

RecordFirmDate
A Clinical Trial of the ACYW135 Group Meningococcal Polysaccharide-Conjugated Vaccine (CRM197 Vector) (NCT07743411)CanSino Biologics Inc.2026-09-15
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months (NCT07505810)Sinovac Biotech Co., Ltd2026-03-25
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years (NCT07505888)Sinovac Biotech Co., Ltd2026-03-22
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months (NCT07505836)Sinovac Biotech Co., Ltd2026-03-22
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months (NCT07505823)Sinovac Biotech Co., Ltd2026-03-22
Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine (NCT07203755)CanSino Biologics Inc.2025-12-19
Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants (NCT06389513)CanSino Biologics Inc.2024-06-12
Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) (NCT05935176)CanSino Biologics Inc.2023-09-20
A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old Population (NCT06011200)CanSino Biologics Inc.2023-09-16

Track Epidemic Meningitis automatically

Every clearance here is in the API, with alerts when new ones post.